Clinical Research
Opportunities

Penn Medicine is conducting studies to develop new ways to prevent, diagnose, and treat disease. You might be eligible to participate

Get Started
Group headshot of people

Clinical Research Opportunities

Penn Medicine is conducting studies to develop new ways to prevent, diagnose, and treat disease. You might be eligible to participate

Penn Medicine is conducting studies to develop new ways to prevent, diagnose, and treat disease. You might be eligible to participate

Penn Medicine is conducting medical studies to develop new diagnostic and clinical treatments to improve current standards of care.

Browse by Condition or Investigator

Browse all Trials

Recently Added/Updated trials

Taste & Saliva Study

18 years - 45 years
Accepts healthy volunteer
All genders
Monell Chemical Senses Center in collaboration with Penn Medicine is conducting a study to understand how people perceive the quality and intensity of different tastes. To take part in this study, you must be healthy, between 18 and 45 years old, fluent in English, and willing to fast for at least one hour prior to each testing session.

TBCRC Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE-BDT)

99 years or below
All genders
This is a multicenter, multi-arm, biomarker-stratified trial designed to evaluate biomarker-directed therapies in patients with estrogen receptor-positive/hormone receptor-negative (ER+/HR-) and triple-negative (TN) metastatic breast cancer (MBC). The trial integrates both retrospective and prospective data collection, including archival tumor tissue, medical record abstraction, and prospective tumor and blood sampling prior to initiation of protocol directed treatment. Based on biomarker subtype, participants will receive standard of care therapy. Liquid biopsy will be collected on Cycle 2 Day 1, and then liquid biopsy, imaging and clinical data will be collected at each re-staging. Treatment will continue until discontinuation for progression, toxicity or at the discretion of the treating physician.
Healthy Volunteer Enteral Nutrition

Healthy Volunteer Enteral Nutrition

18 years - 70 years
Accepts healthy volunteer
All genders
This is an Outpatient clinical trial of 20 healthy people assigned to drink nutritional shakes for either 60% of their calories or 100% of their calories for up to 4 days to understand changes in microbiome and metabolome resulting from consumption of the assigned diet.   Participants assigned to drink the nutritional formula for 60% of their calories will be given food for the other 40% of their calories.  The assignment related to whether you will drink nutritional shakes and food vs. just nutritional shakes is random.  You will not be able to choose your assignment.  Participants may only drink the nutritional formula and the food provided along with water or black coffee for the 4 days of the study. You will need to come for 5 visits.  One visit is for screening to see if you are eligible.  The four other visits will take place in one week and will be in the morning, as fasting before the visit is required.   Blood is collected at screening and on 3 other days. Stool and urine are collected at home around the time of screening and on 5 additional days. Participants are given sitz markers on day 1 and will undergo 1 or 2 x-rays. Diet surveys will also be collected. Participants who complete the entire study will receive $750.
UPCC 07623 Effect of Immune Checkpoint Inhibitors on Coronary Microvasculature

UPCC 07623 Effect of Immune Checkpoint Inhibitors on Coronary Microvasculature

18 years or above
All genders
Observational
This is an observational study that includes patients with breast cancer or non-small cell lung cancer who will be treated with immune checkpoint inhibitor (ICI) therapy. The investigators will use echocardiograms, blood draws, and PET stress tests to understand how ICI therapy affects the heart and circulatory system.

UPCC 03922 A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 193 Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors

18 years - 100 years
All genders
Phase 1/2
Interventional
The primary objective of Parts 1 and 2 of this study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) of Anvumetostat alone and in combination with docetaxel in adult participants with metastatic or locally advanced methylthioadenosine phosphorylase (MTAP)-null solid tumors. The primary objective of Part 3 of this study is to evaluate the efficacy of Anvumetostat in adult participants with metastatic or locally advanced MTAP-null solid tumors.

Volunteer Sign-Up

If you don’t see a trial that fits your needs, consider joining our research volunteer registry. By signing up, you’ll be notified if a study matches your background and health profile.

Healthy Volunteers

Clinical research studies currently seeking healthy individuals.

Virtual Studies

Also called Online or Decentralized studies. Some may be a mix of remote and in-person visits. 

Penn Medicine Logo Small

Penn Medicine experts answer questions from patient advocates and share groundbreaking medical developments happening at the University of Pennsylvania.

View More